Home NDC 69800-4202 Nabi-HB
Product NDC 69800-4202
11-digit product format 698004202
Labeler code 69800
Product ID 69800-4202_ee1560c0-18e1-b617-e053-2a95a90aa1af
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name Hepatitis B Immune Globulin (Human)
Dosage form LIQUID
Route INTRAMUSCULAR
Labeler ADMA Biologics, Inc.
Application BLA103945
Marketing category BLA
Marketing start 2001-10-23
Marketing end 0000-00-00
Substance HUMAN HEPATITIS B VIRUS IMMUNE GLOBULIN
Active strength 312 [iU]/mL
Pharmacologic classes Human Immunoglobulin [EPC], Immunoglobulins [CS], Passively Acquired Immunity [PE], Virus Neutralization [MoA], Virus-specific Hyperimmune Globulins [EXT]
NDC exclude flag No
Listing certified through 2023-12-31
Current FDA listing Historical FDA.report record openFDA label cross-check# Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join Nabi-HB HEPATITIS B IMMUNE GLOBULIN (HUMAN) ADMA Biologics, Inc. 47fe1a99-5078-4b89-84fa-9e8387baec5c 2025-04-10 Warnings, Adverse reactions Exact identifier application number: BLA103945
Purple Book Biologic Products# BLA, Proprietary name, Proper name table BLA Proprietary name Proper name License type Status Latest source 103945 Nabi-HB Hepatitis B Immune Globulin (Human) 351(a) Disc 2026-06-01
Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Marketing start Marketing end Sample Exclude flag Status 69800-4202-1 69800420201 1 VIAL, SINGLE-USE in 1 CARTON (69800-4202-1) > 1 mL in 1 VIAL, SINGLE-USE (69800-4202-2) 2001-10-23 0000-00-00 No No Current